Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
Conditions: Breast Cancer; Breast Cancer Stage I; Breast Cancer Stage II; Breast Cancer Stage III; Breast Cancer Stage IV; Invasive Breast Cancer; Ovarian Cancer; Ovarian Cancer Stage 1; Ovarian Cancer Stage II; Ovarian Cancer Stage III; Ovarian Cancer Stage IV; Ovarian Cancer Stage IA; Ovarian Cancer Stage IB; Ovarian Cancer Stage IC; Ovarian Cancer Stage 2; Ovarian Cancer Stage 3; Ovarian Cancer Stage IIIb; Ovarian Cancer Stage IIIC; Breast Cancer Stage IIIA; Breast Cancer Invasive; Breast Cancer, Stage IA; Breast Cancer, Stage IB; Breast Cancer Stage IIA; Breast Cancer Stage IIB; Breast Cancer Stage IIIB; Breast Cancer ...
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific Antibody
Conditions: Malignant Ascites Interventions: Drug: M701; Drug: paracentesis Sponsors: Wuhan YZY Biopharma Co., Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
Cardiometabolic Consequences of the Loss of Ovarian Function
Conditions: Menopause; Estrogen Deficiency; Aging; Adiposity Interventions: Drug: Degarelix; Drug: Transdermal Estradiol Patch; Drug: Transdermal Placebo Patch Sponsors: University of Colorado, Denver; National Institute on Aging (NIA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
A Phase 1, First-in-Human Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors
Conditions: Solid Tumor; Solid Tumor, Adult; Advanced Solid Tumor; Metastatic Tumor; Ovarian Cancer; Ovarian Neoplasms; Ovarian Carcinoma; Metastatic Ovarian Carcinoma; Endometrial Cancer; Endometrial Neoplasms; Endometrial Diseases; Metastatic Endometrial Cancer; Metastatic Endometrial Carcinoma; Advanced Endometrial Carcinoma; Advanced Ovarian Carcinoma; Gastric Cancer; Advanced Gastric Carcinoma; Metastatic Gastric Cancer; Metastatic Gastric Carcinoma; Small-cell Lung Cancer; Small Cell Lung Carcinoma; Triple Negative Breast Cancer; Triple Negative Breast Neoplasms; Platinum-resistant Ovarian Cancer; Platinum-refractory...
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
Improving the Quality of Cryopreserved Ovarian Tissue Reimplantation Using Platelet-enriched Autologous Plasma
Conditions: Cryopreservation; Ovary Injury; Infertility, Female; Menopause Ovarian Failure Interventions: Procedure: Cryopreserved Ovarian Tissue Reimplantation Sponsors: IRCCS Azienda Ospedaliero-Universitaria di Bologna Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials
A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors
Conditions: Advanced or Metastatic Solid Tumors; Breast Cancer; Recurrent Ovarian Cancer; Prostate Cancer Interventions: Drug: VIO-01 Sponsors: Valerio Therapeutics Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
A Clinical Study of Baozhu Keli in the Treatment of Ovarian Aging
Conditions: Ovarian Aging Interventions: Drug: Baozhu Keli Sponsors: Tongji Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome
Conditions: Polycystic Ovary Syndrome; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Canagliflozin 100mg Tab; Drug: Metformin Hydrochloride Sponsors: Ping Li,MD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
Conditions: Malignant Mesothelioma; Colorectal Cancer; Bile Duct Cancer; Rectal Cancer; Ovary Cancer; Pancreatic Cancer; Breast Cancer Female Interventions: Biological: UCMYM802 Injection Sponsors: UTC Therapeutics Inc.; Peking University Cancer Hospital& Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
Conditions: Breast Cancer; Small Cell Lung Cancer; Ovarian Cancer; Gastric Cancer; Hormone-receptor-positive Breast Cancer; Hormone Receptor Positive HER-2 Negative Breast Cancer; Advanced Solid Tumor; Endometrial Cancer; Prostate Cancer Interventions: Drug: BG-68501; Drug: Fulvestrant Sponsors: BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Clinical and Pathological Characteristics of Women With Ovarian Cancers in Syria
Conditions: Ovarian Cancer Sponsors: Tishreen University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Luspatercept in Metastatic AGCT of the Ovary
Conditions: Adult Granulosa Cell Tumor of the Ovary Interventions: Drug: Luspatercept Sponsors: University Health Network, Toronto Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
Conditions: Metastatic Solid Cancers; Colorectal Cancer; Breast Cancer; Non-Small Cell Lung Cancer; Gastrointestinal Cancer; Ovarian Cancer; Genitourinary Cancer Interventions: Drug: Aldesleukin; Drug: Fludarabine; Drug: Cyclophosphamide; Biological: KRAS TCR-Transduced PBL; Biological: GRT-C903/GRT-R904 Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen
Conditions: Ovarian Cancer; Cervical Cancer Interventions: Drug: Efbemalenograstim Alfa Sponsors: Shandong University; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
Exercise and Nutrition Intervention in Ovarian Cancer
Conditions: Ovarian Cancer; Malnutrition; Muscle Wasting; Fatigue Interventions: Behavioral: combined exercise and nutrition intervention Sponsors: Universit ätsklinikum Hamburg-Eppendorf; Charite University, Berlin, Germany; University Hospital Dresden; Kliniken Essen-Mitte; University Hospital Tuebingen; University Hospital Schleswig-Holstein; Technical University of Munich Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
